SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

1AD (1AD) News

Track canonical SquawkNews coverage tagged to 1AD, 1AD. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 1AD Asset market Sector Markets 90 days 1 Updated Sep 02, 2026, 03:06 AM UTC Open live news feed
M AdAlta partner gets China approval for armored CAR-T mesothelioma therapy Shanghai Cell Therapy Group, AdAlta’s co-development partner, received approval to provide BZDS1901 first-in-class armored CAR-T therapy to eligible patients with advanced mesothelioma under China’s special access scheme GEOPOLITICS | Sep 02, 2026, 03:06 AM UTC